: It is well established that gender strongly influences cardiovascular risk factors, playing a crucial role in cardiovascular prevention, clinical pathways, diagnostic approach and treatment. Beyond the sex, which is a biological factor, gender entails a socio-cultural condition that impacts access and quality of care due to structural and institutional barriers. However, despite its great importance, this issue has not been adequately covered. Indeed sex and gender differences scarcely impact the clinical approach, creating a lot of disparities in care and outcomes of patients. Therefore, it becomes essential to increase the awareness of the importance of sex and gender influences on cardiovascular diseases. Moreover, new strategies for reducing disparities should be developed. Importantly, these differences should be taken into account in guideline recommendations. In this regard, it is crucial to include a greater number of women in clinical trials, since they are currently underrepresented. Furthermore, more women should be involved as member of international boards in order to develop recommendations and guidelines with more attention to this important topic.The aim of this ANMCO position paper is to shed light on gender differences concerning many cardiovascular drugs in order to encourage a more personalized therapeutic approach.

Position paper ANMCO: Differenze di genere nell’approccio farmacologico cardiovascolare / Lucà, Fabiana; Pavan, Daniela; Massimo Gulizia, Michele; Teresa Manes, Maria; Giuseppe Abrignani, Maurizio; Antonio Benedetto, Francesco; Bisceglia, Irma; Brigido, Silvana; Caldarola, Pasquale; Calvanese, Raimondo; Laura Canale, Maria; Caretta, Giorgio; Ceravolo, Roberto; Chieffo, Alaide; Chimenti, Cristina; Cornara, Stefano; Cutolo, Ada; Angela Di Fusco, Stefania; Di Matteo, Irene; Di Nora, Concetta; Fattirolli, Francesco; Favilli, Silvia; Maura Francese, Giuseppina; Gelsomino, Sandro; Geraci, Giovanna; Giubilato, Simona; Ingianni, Nadia; Iorio, Annamaria; Lanni, Francesca; Montalto, Andrea; Nardi, Federico; Navazio, Alessandro; Nesti, Martina; Parrini, Iris; Pilleri, Annarita; Pozzi, Andrea; Massimiliano Rao, Carmelo; Riccio, Carmine; Rossini, Roberta; Scicchitano, Pietro; Valente, Serafina; Zuccalà, Giuseppe; Gabrielli, Domenico; Grimaldi, Massimo; Colivicchi, Furio; Oliva, Fabrizio. - In: GIORNALE ITALIANO DI CARDIOLOGIA. - ISSN 1972-6481. - 25:2(2024). [10.1714/4187.41763]

Position paper ANMCO: Differenze di genere nell’approccio farmacologico cardiovascolare

Cristina Chimenti;Francesca Lanni;Andrea Montalto;Carmine Riccio;Domenico Gabrielli;Fabrizio Oliva
2024

Abstract

: It is well established that gender strongly influences cardiovascular risk factors, playing a crucial role in cardiovascular prevention, clinical pathways, diagnostic approach and treatment. Beyond the sex, which is a biological factor, gender entails a socio-cultural condition that impacts access and quality of care due to structural and institutional barriers. However, despite its great importance, this issue has not been adequately covered. Indeed sex and gender differences scarcely impact the clinical approach, creating a lot of disparities in care and outcomes of patients. Therefore, it becomes essential to increase the awareness of the importance of sex and gender influences on cardiovascular diseases. Moreover, new strategies for reducing disparities should be developed. Importantly, these differences should be taken into account in guideline recommendations. In this regard, it is crucial to include a greater number of women in clinical trials, since they are currently underrepresented. Furthermore, more women should be involved as member of international boards in order to develop recommendations and guidelines with more attention to this important topic.The aim of this ANMCO position paper is to shed light on gender differences concerning many cardiovascular drugs in order to encourage a more personalized therapeutic approach.
2024
gender, cardiovascular diseases, drugs
01 Pubblicazione su rivista::01a Articolo in rivista
Position paper ANMCO: Differenze di genere nell’approccio farmacologico cardiovascolare / Lucà, Fabiana; Pavan, Daniela; Massimo Gulizia, Michele; Teresa Manes, Maria; Giuseppe Abrignani, Maurizio; Antonio Benedetto, Francesco; Bisceglia, Irma; Brigido, Silvana; Caldarola, Pasquale; Calvanese, Raimondo; Laura Canale, Maria; Caretta, Giorgio; Ceravolo, Roberto; Chieffo, Alaide; Chimenti, Cristina; Cornara, Stefano; Cutolo, Ada; Angela Di Fusco, Stefania; Di Matteo, Irene; Di Nora, Concetta; Fattirolli, Francesco; Favilli, Silvia; Maura Francese, Giuseppina; Gelsomino, Sandro; Geraci, Giovanna; Giubilato, Simona; Ingianni, Nadia; Iorio, Annamaria; Lanni, Francesca; Montalto, Andrea; Nardi, Federico; Navazio, Alessandro; Nesti, Martina; Parrini, Iris; Pilleri, Annarita; Pozzi, Andrea; Massimiliano Rao, Carmelo; Riccio, Carmine; Rossini, Roberta; Scicchitano, Pietro; Valente, Serafina; Zuccalà, Giuseppe; Gabrielli, Domenico; Grimaldi, Massimo; Colivicchi, Furio; Oliva, Fabrizio. - In: GIORNALE ITALIANO DI CARDIOLOGIA. - ISSN 1972-6481. - 25:2(2024). [10.1714/4187.41763]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1727528
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? ND
social impact